Eschbach, Germany

Ernst Küsters

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2005-2016

Loading Chart...
Loading Chart...
6 patents (USPTO):

Certainly! Here is the article about inventor Ernst Küsters:

Title: Innovator Spotlight: Ernst Küsters - Pioneering Pharmacologist at Novartis AG

Introduction:

Ernst Küsters, a distinguished inventor based in Eschbach, Germany, has been making waves in the field of pharmacology with his groundbreaking patents and innovative contributions. With a total of 5 patents to his name, Küsters' work has significantly impacted the medical and pharmaceutical industries.

Latest Patents:

Among his latest patents is the development of Aminoalkanol derivatives, a class of compounds with promising pharmacological properties. Additionally, Küsters has also introduced a novel manufacturing process for an iron-containing phosphate adsorbent, designed to treat hyperphosphatemia effectively.

Career Highlights:

Ernst Küsters currently serves as a key figure at Novartis AG, a renowned pharmaceutical company at the forefront of cutting-edge research and development. His role in the company has been instrumental in driving forward advancements in drug discovery and medical treatments.

Collaborations:

Throughout his career, Küsters has collaborated closely with esteemed colleagues such as Peter Koch and Heinz Unternährer. Together, they have combined their expertise to push the boundaries of pharmacological innovation and create impactful solutions for complex medical challenges.

Conclusion:

In conclusion, Ernst Küsters stands as a leading figure in the realm of pharmacology, with his inventive spirit and commitment to excellence setting him apart as a true trailblazer in the field. His patents and collaborations reflect a legacy of innovation that continues to shape the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…